Literature DB >> 30111548

Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency.

John Vissing1, H Orhan Akman2, Jan Aasly2, Stephen G Kahler2, Carlos A Bacino2, Salvatore DiMauro2, Ronald G Haller2.   

Abstract

OBJECTIVE: To study the variable clinical picture and exercise tolerance of patients with phosphoglycerate kinase (PGK) 1 deficiency and how it relates to residual PGK enzyme activity.
METHODS: In this case series study, we evaluated 7 boys and men from 5 families with PGK1 deficiency. Five had pure muscle symptoms, while 2 also had mild intellectual disability with or without anemia. Muscle glycolytic and oxidative capacities were evaluated by an ischemic forearm exercise test and by cycle ergometry.
RESULTS: Enzyme levels of PGK were 4% to 9% of normal in red cells and 5% to10% in muscle in pure myopathy patients and 2.6% in both muscle and red cells in the 2 patients with multisystem involvement. Patients with pure myopathy had greater increases in lactate with ischemic exercise (2-3 mmol/L) vs the 2 multisystem-affected patients (<1 mmol/L). Myopathy patients had higher oxidative capacity in cycle exercise vs multisystem affected patients (≈30 vs ≈15 mL/kg per minute). One multisystem-affected patient developed frank myoglobinuria after the short exercise test.
CONCLUSIONS: This case series study of PGK1 deficiency suggests that the level of impaired glycolysis in PGK deficiency is a major determinant of phenotype. Lower glycolytic capacity in PGK1 deficiency seems to result in multisystem involvement and increased susceptibility to exertional rhabdomyolysis.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30111548     DOI: 10.1212/WNL.0000000000006165

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Integrated Multiomics Analysis of Salivary Exosomes to Identify Biomarkers Associated with Changes in Mood States and Fatigue.

Authors:  Whitaker Cohn; Chunni Zhu; Jesus Campagna; Tina Bilousova; Patricia Spilman; Bruce Teter; Feng Li; Rong Guo; David Elashoff; Greg M Cole; Alon Avidan; Kym Francis Faull; Julian Whitelegge; David T W Wong; Varghese John
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

2.  Novel heterozygous mutations in the PGAM2 gene with negative exercise testing.

Authors:  M Sidhu; L Brady; G D Vladutiu; M A Tarnopolsky
Journal:  Mol Genet Metab Rep       Date:  2018-10-09

3.  Protein Signature in Saliva of Temporomandibular Disorders Myalgia.

Authors:  Hajer Jasim; Malin Ernberg; Anders Carlsson; Björn Gerdle; Bijar Ghafouri
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

4.  Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC).

Authors:  Renata S Scalco; Alejandro Lucia; Alfredo Santalla; Andrea Martinuzzi; Marinela Vavla; Gianluigi Reni; Antonio Toscano; Olimpia Musumeci; Nicol C Voermans; Carlyn V Kouwenberg; Pascal Laforêt; Beatriz San-Millán; Irene Vieitez; Gabriele Siciliano; Enrico Kühnle; Rebeca Trost; Sabrina Sacconi; Mads G Stemmerik; Hacer Durmus; Biruta Kierdaszuk; Andrew Wakelin; Antoni L Andreu; Tomàs Pinós; Ramon Marti; Ros Quinlivan; John Vissing
Journal:  Orphanet J Rare Dis       Date:  2020-11-24       Impact factor: 4.123

5.  Energy metabolism during exercise in patients with β-enolase deficiency (GSDXIII).

Authors:  Astrid Emilie Buch; Olimpia Musumeci; Ralph Wigley; Mads Peter Godtfeldt Stemmerik; Anne-Sofie Vibæk Eisum; Karen Lindhardt Madsen; Nicolai Preisler; David Hilton-Jones; Ros Quinlivan; Antonio Toscano; John Vissing
Journal:  JIMD Rep       Date:  2021-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.